8-K: PACS Group Appoints Dr. Patrick Conway to Board

PACS Group, Inc. announced the appointment of Dr. Patrick H. Conway, former CMS Deputy Administrator and current CEO of Optum, to its Board of Directors, effective immediately.

Summary

• PACS Group, Inc. appointed Dr. Patrick H. Conway, MD, MSc to its Board of Directors, effective March 4, 2026.
• Dr. Conway will serve as a Class III director for a term expiring at the Company's annual meeting of stockholders in 2027.
• He will participate in the compensation program for non-employee directors and enter into the Company's standard indemnification agreement.
• Dr. Conway is currently the CEO of Optum, the health services division of UnitedHealth Group, which has revenues exceeding $200 billion.
• His prior roles include Deputy Administrator for Innovation and Quality at the U.S. Centers for Medicare and Medicaid Services (CMS), where he was instrumental in shifting Medicare payments towards value-based care.
• PACS Group operates over 320 post-acute care facilities across 17 states, serving more than 31,700 patients daily.
• The company reported full-year 2025 revenue of $5.29 billion, representing 29.3% growth year-over-year.
• 73.4% of PACS Group's skilled nursing portfolio is rated 4 or 5 stars on the CMS Quality Measure Star rating, and occupancy rates in mature facilities are nearly 17 percentage points above the industry average.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a highly positive development, given Dr. Conway's unparalleled expertise and strategic value to PACS Group in a complex and evolving healthcare sector.

Positives

• The appointment of Dr. Patrick H. Conway, a highly accomplished physician-executive with extensive experience in clinical care, federal regulatory leadership (CMS), and large-scale health system executive roles (Optum, Blue Cross NC), significantly strengthens the Board.
• Dr. Conway's deep expertise in quality, value-based care, and healthcare innovation is expected to provide unparalleled strategic guidance to PACS Group.
• His firsthand insight into CMS regulatory frameworks, payment models, and quality metrics (including star ratings) offers a significant advantage for navigating the evolving post-acute care landscape.
• PACS Group demonstrated strong financial performance with full-year 2025 revenue of $5.29 billion, representing 29.3% growth year-over-year.
• The company maintains high quality ratings for its facilities, with 73.4% of its skilled nursing portfolio rated 4 or 5 stars on the CMS Quality Measure Star rating.
• Occupancy rates nearly 17 percentage points above the industry average in mature facilities indicate robust operational performance and demand for PACS's services.

Risks

• The post-acute and skilled nursing industry is navigating increasing clinical complexity.
• The industry is facing shifting reimbursement models.
• There is growing regulatory scrutiny in the healthcare sector.
• Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those implied.

Future Outlook

The filing highlights that Dr. Conway's perspective is uniquely positioned to help PACS chart its strategic course as the industry navigates increasing clinical complexity, shifting reimbursement models, and growing regulatory scrutiny. His expertise in designing payment models and quality metrics is expected to give PACS a rare advantage in understanding and navigating the evolving policy landscape.

Management Comments

• "We are truly honored to welcome Dr. Patrick Conway to the PACS Board of Directors. Dr. Conways career is extraordinary by any measure. He has served at the very highest levels of American healthcare as a practicing physician, as the nations chief architect of Medicare and Medicaid payment reform, as the CEO of one of the most prominent health insurers in the country, and now as the leader of Optum, which connects care across settings to make it more coordinated, affordable and easier for patients to navigate. The depth and breadth of knowledge and perspective he brings to our Board is unlike anything the post-acute and skilled nursing sector has seen. For PACS, this is transformative." Jason Murray, Chairman and CEO of PACS Group.
• "Dr. Conway didn't just study the healthcare system he helped shape it. The payment models he built at CMS, the quality frameworks he championed, and the scale at which he has led health services organizations are directly relevant to everything we do at PACS. As we continue to grow, innovate, and set the standard for post-acute care in this country, having a physician of his caliber and a healthcare leader of his stature guiding our Board will be an extraordinary asset for our company, our patients, our employees, and our shareholders." Jason Murray, Chairman and CEO of PACS Group.
• "Post-acute care is one of the most important and underappreciated parts of the American healthcare system. As acuity continues to shift from acute to post-acute settings, and as our population ages, the role skilled nursing providers play in delivering high-quality, cost-effective care has never been more critical. PACSs commitment to clinical excellence, quality outcomes, and transformative leadership in this space aligns with everything I have dedicated my career to. I look forward to working with Jason and the entire PACS Board and leadership team to help advance the organizations mission and impact." Dr. Patrick Conway.

Industry Context

StockSavvy.ai notes that the appointment of Dr. Patrick Conway, a figure with deep experience in both federal healthcare policy (CMS) and large-scale health services management (Optum), is a significant strategic move for PACS Group. This aligns with a broader industry trend where post-acute care providers are increasingly seeking expertise to navigate complex regulatory environments, optimize value-based care models, and enhance operational efficiency amidst an aging population and shifting care delivery paradigms. His background directly addresses the critical need for strategic leadership in an evolving healthcare landscape.

Comparison to Industry Standards

• PACS Group's 73.4% of skilled nursing portfolio rated 4 or 5 stars on the CMS Quality Measure Star rating indicates strong performance compared to industry averages, as these ratings are a key benchmark for quality in skilled nursing.
• Occupancy rates nearly 17 percentage points above the industry average in mature facilities demonstrate superior operational efficiency and demand for PACS's services compared to its peers.
• Dr. Conway's leadership at CMS, where Medicare payments in alternative payment models grew from virtually zero to over 30%, sets a high standard for driving value-based care transformation, a benchmark PACS aims to leverage.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for enhanced strategic guidance and improved navigation of regulatory complexities, leading to better long-term performance and value creation.
• Patients: Dr. Conway's commitment to improving healthcare quality and value-based care aligns with PACS's mission to deliver high-quality care.
• Employees: Stronger leadership and strategic direction could foster a more stable and growth-oriented environment.
• Regulatory Authorities: The appointment of a former high-ranking CMS official could signal a proactive approach to regulatory compliance and engagement.

Next Steps

• Dr. Conway will serve as a Class III director for a term expiring at the Company's annual meeting of stockholders to be held in 2027.
• His successor will be duly elected and qualified or he will serve until his earlier death, resignation, disqualification or removal.
• PACS Group will continue to grow, innovate, and set the standard for post-acute care.

Key Dates

Recommendation

The appointment of Dr. Patrick Conway, a highly influential figure in U.S. healthcare policy and operations, significantly strengthens PACS Group's strategic capabilities. His deep expertise in value-based care, CMS regulations, and large-scale health services management provides a unique competitive advantage for navigating the complex post-acute care sector. This strategic enhancement, combined with PACS Group's strong financial performance and quality metrics, positions the company for continued growth and market leadership, making it a compelling 'strong buy' for long-term investors.

Keywords

PACS Group, Board of Directors, Patrick Conway, Optum, CMS, post-acute care, skilled nursing, healthcare, corporate governance, value-based care, Medicare, Medicaid, director appointment